NEW YORK, Feb. 18, 2016 -- The Nasdaq Stock Market® (Nasdaq:NDAQ) announced that trading was halted today in G. Willi-Food International Ltd. (Nasdaq:WILC) at 10:10:27 Eastern Time for "additional information requested" from the company at a last price of $3.75.
Trading will remain halted until G. Willi-Food International Ltd. has fully satisfied Nasdaq’s request for additional information.
For news and additional information about the company, please contact the company directly or check under the company’s symbol using InfoQuotesSM on the Nasdaq® Web site.
For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com.
NDAQO
Nasdaq Media Contact: Peter Gau +1.212.231.5475 [email protected]


Kia Cuts EV Prices in Europe as Chinese Carmakers Intensify Competition
Nippon Express Stock Jumps as Elliott Investment Signals Strong Foreign Interest in Japan Logistics Sector
Toyota Global Vehicle Sales Decline in March Amid RAV4 Transition and Middle East Slowdown
Air Liquide Q1 Revenue Misses Estimates Amid Currency and Energy Headwinds
U.S. Warns Allies Over Alleged Chinese AI IP Theft Linked to DeepSeek
Micro Systemation Reports Q1 Loss Amid Strategic Investments and Revenue Growth
WuXi AppTec Stock Surges on Strong Q1 Earnings and CRDMO Demand Growth
OpenAI Faces Revenue Pressure and User Growth Challenges Ahead of IPO
Taiwan Court Fines Tokyo Electron Unit $4.78M in Major TSMC Trade Secrets Case
Novartis Q1 2026 Earnings Miss Expectations as Generic Competition Pressures Sales
China’s Ultra-Cheap EV Boom: Why Electric Cars Cost Far Less Than in the U.S.
U.S. Demand for Alternative Satellite Providers Remains Strong Amid SpaceX Regulatory Push
DeepSeek Slashes AI Model Pricing to Boost Adoption and Challenge Global Rivals
Nomura Shares Drop After Profit Miss Despite Strong Revenue Growth
Lightelligence IPO Soars Over 400% in Hong Kong Debut Amid Rising AI Investment Demand
Advantest Stock Falls on Weak Outlook Despite Strong AI-Driven Results
Sun Pharma to Acquire Organon in $11.75 Billion Deal to Boost Global Women’s Health Portfolio 



